The dangerous drug attorneys of Nadrich & Cohen Accident Injury Lawyers and its legal teams are actively investigating and pursuing lawsuits on behalf of Xeljanz and Xeljanz XR patients and their families. You may be eligible for financial compensation if you or a loved one died or developed a blood clot while using Xeljanz or Xeljanz XR.
Call us now at 1-800-718-4658 to learn more about your right to compensation. You can also use the live chat feature or complete the contact form on this page. A member of our Xeljanz lawsuit intake team will contact you and review your potential claim. There is no charge for the consultation and we will never charge you unless we first obtain a recovery for you.
Xeljanz Safety Concerns
The FDA said that as of January 2019, their Xeljanz safety trial showed 19 cases of blood clots in the lung out of 3,884 patient-years of follow-up in patients receiving 10mg of tofacitinib twice daily, compared to 3 cases out of 3,982 patient-years in patients receiving TNF blockers. The FDA also said that the trial showed 45 cases of death from all causes out of 3,884 patient-years of follow-up in patients receiving 10mg of tofacitinib twice daily, compared to 25 cases out of 3,982 patient-years in patients receiving TNF blockers.
The FDA has alerted the public that preliminary clinical safety trial results show that Xeljanz is linked with an increased risk of cancer and serious heart-related problems compared to tumor necrosis factor inhibitors. The safety trial also investigated other risks such as death and blood clots in the lungs, but those results are not available yet.
The FDA has also delayed a review of Xeljanz by three months. This possibly signals that the FDA is about to hold an advisory committee that will review the benefit/risk profiles of JAK inhibitors such as Xeljanz for the treatment of atopic dermatitis, according to SVB Leerink’s Geoffrey Porges.
Xeljanz Cardiovascular Side Effects
- Deep vein Thrombosis
- Pulmonary Embolism
The U.S. Food and Drug Administration (FDA) approved Xeljanz in November 2012 for treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Xeljanz XR was later approved in February 2016. Xeljanz XR is an extended release version which only needs to be taken once per day.
The FDA issued a drug safety communication about Xeljanz in February 2019. The communication said rheumatoid arthritis patients who take 10 mg of tofacitinib (the active ingredient in Xeljanz and Xeljanz XR) twice per day face an increased risk of death and blood clots in the lungs.
The FDA later approved a Boxed Warning for Xeljanz in July 2019. The warning concerned an increased risk of blood clots and death in ulcerative colitis patients who take 10 mg of tofacitinib twice per day.
How To Join Xeljanz Lawsuit
You can file a Xeljanz lawsuit for free with us and you will never be charged a single penny out of your own pocket for it. Nadrich & Cohen Accident Injury Lawyers operates on a contingency fee basis. This means that we only charge clients a portion of their recovery if and only if we obtain said recovery for them. No win, no fee! There will never be any upfront cost to you.
Contact the Xeljanz side effect attorneys of Nadrich & Cohen Accident Injury Lawyers now for a free consultation if you or a loved one died or developed a blood clot while using Xeljanz or Xeljanz XR. Let us advise you of your legal rights.
Call us now for a free consultation at 1-800-718-4658, use the live chat feature or complete the contact form on this page.